PTGDR and asthma: Evidence suggests that preventing the activation of the prostaglandin D2 receptor (DP2) pathway improves symptoms of asthma and pulmonary function, and impairs any change in eosinophil shape, while indirectly inducing a reduction in the number of exacerbations in severe asthmatic patients [83].